Skip to main content

Table 3 Logistic regression analysis evaluating the association between risk factors and outcomes at discharge in all 471 patients

From: Impact of the COVID-19 pandemic on cerebral venous sinus thrombosis in China: a comparative study

Risk Factor

Unadjusted OR

(95% CI)

P value

Adjusted OR

(95% CI)

P value

CNS infection

6.013 (1.390–26.011)

0.016

0.615 (0.099–3.823)

0.602

Obstetric causes

1.116 (0.553–2.253)

0.759

-

-

Oral contraceptives, HRT

1.995 (1.043–3.819)

0.037

3.000 (0.556–16.186)

0.201

Hematologic disorders

1.947 (1.115–3.397)

0.019

1.778 (0.411–7.697)

0.442

 Anemia

2.232 (1.213–4.107)

0.010

6.000 (1.445–24.919)

0.014

 Polycythemia

4.426 (0.725–27.028)

0.107

2.889 (0.325–25.702)

0.341

 Transfusion

1.639 (0.340–7.901)

0.538

-

-

Prothrombotic conditions

1.901 (1.093–3.304)

0.023

1.821 (0.885–3.747)

0.104

 PS reduction

1.604 (0.934–2.754)

0.087

0.482 (0.129–1.795)

0.277

 AT reduction

1.429 (0.567–3.601)

0.450

-

-

 Hyperhomocysteinemia

1.479 (0.742–2.946)

0.266

-

-

 Antiphospholipid and anticardiolipin antibodies

1.119 (0.479–2.616)

0.795

-

-

Any malignancies

1.454 (0.307–6.887)

0.637

-

-

  1. Abbreviations: CNS Central nervous system, HRT Hormone replacement therapy, PS Protein S, AT Antithrombin, OR Odds ratio, 95% CI 95% confidence interval, - not included in the analysis